- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.12.25 | BioMarin snaps up Amicus Therapeutics for $4.8bn amid rare disease push | ||
| 22.12.25 | UK approves Gilead's twice-yearly HIV PrEP drug | ||
| 22.12.25 | Trump administration ties pricing deals with another nine pharma companies | ||
| 22.12.25 | Cytokinetics receives FDA approval for MYQORZO tablets for oHCM | ||
| 22.12.25 | AstraZeneca pulls Andexxa from US market after post-marketing fatalities | ||
| 22.12.25 | MEDIPOST, Teikoku Seiyaku partner for CARTISTEM commercialisation in Japan | ||
| 22.12.25 | Novartis, US government reach agreement to lower drug prices | ||
| 19.12.25 | Nxera seeks schizophrenia programme buyer after Boehringer snub | ||
| 19.12.25 | Takeda to seek approval of plaque psoriasis pill on Phase III trial data | ||
| 19.12.25 | Eli Lilly's oral GLP-1RA maintains weight loss from injectable drugs | ||
| 19.12.25 | MHRA launches call for evidence on AI regulation in UK healthcare sector | ||
| 19.12.25 | J&J receives FDA approval for lung cancer therapy | ||
| 18.12.25 | FDA approves meningioma label warning on Pfizer's contraceptive injection | ||
| 18.12.25 | BIOSECURE Act set for Trump's signature after Congress approval | ||
| 18.12.25 | EC approves Incyte's Minjuvi combo for follicular lymphoma | ||
| 18.12.25 | Alnylam plans $250m investment in Norton manufacturing facility, US | ||
| 17.12.25 | CDC ends universal newborn hepatitis B vaccine recommendations | ||
| 17.12.25 | GSK obtains FDA approval for Exdensur in severe asthma | ||
| 17.12.25 | Harbour BioMed and BMS sign multi-specific antibody collab | ||
| 17.12.25 | Precision medicine approaches needed in oncology to match evolving SoC | ||
| 17.12.25 | INCOG reveals $200m injectable drug expansion in Indiana | ||
| 16.12.25 | Sanofi signs pair of billion-dollar biotech deals to bolster pipeline | ||
| 16.12.25 | Pfizer trims 2026 profit forecast amid Covid headwinds and patent cliff pressures | ||
| 16.12.25 | LEO Pharma applies to EMA to expand Anzupgo use to adolescents | ||
| 16.12.25 | SK Capital Partners supports Swixx BioPharma's global expansion |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .